These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 19796699

  • 1. Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
    la Fougère C, Böning G, Bartmann H, Wängler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Förster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, Cumming P.
    Neuroimage; 2010 Jan 15; 49(2):1406-15. PubMed ID: 19796699
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies.
    Laćan G, Plenevaux A, Rubins DJ, Way BM, Defraiteur C, Lemaire C, Aerts J, Luxen A, Cherry SR, Melega WP.
    Eur J Nucl Med Mol Imaging; 2008 Dec 15; 35(12):2256-66. PubMed ID: 18604533
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Influence of P-glycoprotein on brain uptake of [18F]MPPF in rats.
    Passchier J, van Waarde A, Doze P, Elsinga PH, Vaalburg W.
    Eur J Pharmacol; 2000 Nov 03; 407(3):273-80. PubMed ID: 11068023
    [Abstract] [Full Text] [Related]

  • 7. Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects.
    Lothe A, Boni C, Costes N, Gorwood P, Bouvard S, Le Bars D, Lavenne F, Ryvlin P.
    Neuroimage; 2009 Aug 15; 47(2):482-92. PubMed ID: 19409499
    [Abstract] [Full Text] [Related]

  • 8. Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.
    Elsinga PH, Hendrikse NH, Bart J, van Waarde A, Vaalburg W.
    Mol Imaging Biol; 2005 Aug 15; 7(1):37-44. PubMed ID: 15912274
    [Abstract] [Full Text] [Related]

  • 9. Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study.
    Frey BN, Rosa-Neto P, Lubarsky S, Diksic M.
    Neuroimage; 2008 Aug 15; 42(2):850-7. PubMed ID: 18583156
    [Abstract] [Full Text] [Related]

  • 10. P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain.
    Choi JY, Song JS, Lee M, Cho WK, Chung J, Lyoo CH, Kim CH, Park J, Lee KC, Kim KM, Kang JH, Bae MA, Ryu YH.
    Mol Imaging Biol; 2016 Apr 15; 18(2):267-73. PubMed ID: 26250653
    [Abstract] [Full Text] [Related]

  • 11. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY.
    Liow JS, Lu S, McCarron JA, Hong J, Musachio JL, Pike VW, Innis RB, Zoghbi SS.
    Synapse; 2007 Feb 15; 61(2):96-105. PubMed ID: 17117422
    [Abstract] [Full Text] [Related]

  • 12. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
    Plenevaux A, Weissmann D, Aerts J, Lemaire C, Brihaye C, Degueldre C, Le Bars D, Comar D, Pujol J, Luxen A.
    J Neurochem; 2000 Aug 15; 75(2):803-11. PubMed ID: 10899958
    [Abstract] [Full Text] [Related]

  • 13. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
    Liow JS, Zoghbi SS, Hu S, Hall MD, Hines CS, Shetty HU, Araneta MD, Page EM, Pike VW, Kreisl WC, Herscovitch P, Gottesman MM, Theodore WH, Innis RB.
    Neuroimage; 2016 Sep 15; 138():134-140. PubMed ID: 27211474
    [Abstract] [Full Text] [Related]

  • 14. Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy.
    Bartmann H, Fuest C, la Fougere C, Xiong G, Just T, Schlichtiger J, Winter P, Böning G, Wängler B, Pekcec A, Soerensen J, Bartenstein P, Cumming P, Potschka H.
    Epilepsia; 2010 Sep 15; 51(9):1780-90. PubMed ID: 20633036
    [Abstract] [Full Text] [Related]

  • 15. Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats.
    Defraiteur C, Lemaire C, Luxen A, Plenevaux A.
    Nucl Med Biol; 2006 Jul 15; 33(5):667-75. PubMed ID: 16843842
    [Abstract] [Full Text] [Related]

  • 16. In vivo characterization of p-[(18)F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT(1a) receptors.
    Ginovart N, Hassoun W, Le Bars D, Weissmann D, Leviel V.
    Synapse; 2000 Mar 01; 35(3):192-200. PubMed ID: 10657026
    [Abstract] [Full Text] [Related]

  • 17. A reduced extracellular serotonin level increases the 5-HT1A PET ligand 18F-MPPF binding in the rat hippocampus.
    Zimmer L, Rbah L, Giacomelli F, Le Bars D, Renaud B.
    J Nucl Med; 2003 Sep 01; 44(9):1495-501. PubMed ID: 12960198
    [Abstract] [Full Text] [Related]

  • 18. Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar.
    Kreisl WC, Bhatia R, Morse CL, Woock AE, Zoghbi SS, Shetty HU, Pike VW, Innis RB.
    J Nucl Med; 2015 Jan 01; 56(1):82-7. PubMed ID: 25500831
    [Abstract] [Full Text] [Related]

  • 19. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
    Udo de Haes JI, Cremers TI, Bosker FJ, Postema F, Tiemersma-Wegman TD, den Boer JA.
    Neuropsychopharmacology; 2005 Sep 01; 30(9):1624-31. PubMed ID: 15827572
    [Abstract] [Full Text] [Related]

  • 20. 18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging.
    Vidal B, Fieux S, Colom M, Billard T, Bouillot C, Barret O, Constantinescu C, Tamagnan G, Newman-Tancredi A, Zimmer L.
    Brain Struct Funct; 2018 Jul 01; 223(6):2973-2988. PubMed ID: 29730825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.